medline.ch Hämatologie Anderes

	Disease-specific heterogeneity of C-reactive protein across 21 hematologic disorders reflects divergent inflammatory and hematopoietic phenotypes. Front Immunol Guo H, Zhou J, Wang X, Wang D, Sun L. PMID: 42824385 [PubMed - indexed for MEDLINE]
	Targeted next-generation sequencing in sepsis-associated lymphopenia: a concordance analysis with conventional microbiological testing. Front Cell Infect Microbiol Xu Y, Ren J, Zheng Y, Huang L, Xie Y, Cui N. PMID: 42823985 [PubMed - indexed for MEDLINE]
	Mitochondrial genetic variation as a novel predictor of graft-versus-host disease after stem-cell transplantation in myelodysplastic neoplasms. J Hematol Oncol Arsang-Jang S, Zhang T, Rafati M, Bolon YT, Spellman SR, Chen Z, Jones K, Liu J, Jurdi NE, Gai X, Urrutia R, Gadalla SM, Auer PL, Saber W, Dong J. PMID: 42823733 [PubMed - indexed for MEDLINE]
	Immunoglobulin a Deficiency in Coeliac Disease: A Scoping Review. United European Gastroenterol J Bech K, Crawley C, Choung RS, Murray JA, Husby S. PMID: 42820738 [PubMed - indexed for MEDLINE]
	At the heart of unmet need: TP53 myeloid neoplasms. Lancet Haematol Komrokji RS, Sallman DA. PMID: 42822479 [PubMed - indexed for MEDLINE]
	Felzartamab plus lenalidomide-dexamethasone versus lenalidomide-dexamethasone for relapsed or refractory multiple myeloma: an open-label, parallel-controlled, randomised, phase 3 trial. Lancet Haematol He H, Shang J, Wang Y, Xia Z, Zhu F, Yang Y, Fang B, Chen W, Chen B, Cai Z, Zhou H, Li Y, Liu H, Chen L, Liu Y, Huang Z, Zeng P, Jin J, Li Y, Mi J, Zhou Z, Gao S, Xi Y, Wang Q, Chang C, Du X, Huang SY, Wang HY, Ko PS, Shao Z, Luo J, Wang S, Huang J, Dai M, Yang T, Zhan R, Liang B, Wang MC, Wu S, Zhong L, Wei Y, Wang H, Wu H, Li J, Teng CL, Meng Y, Wu M, Yang P, Chen X, Zhu AX, Fu W, Wu D, Fu C. PMID: 42822478 [PubMed - indexed for MEDLINE]
	Development and temporal validation of a machine learning-based model for predicting renal impairment in multiple myeloma: a single-center retrospective cohort study. BMC Med Inform Decis Mak Zhou M, Feng S. PMID: 42816840 [PubMed - indexed for MEDLINE]
	Fatal TAFRO syndrome in which adrenal hemorrhage preceded thrombocytopenia. J Clin Exp Hematop Miyazaki M, Tsunemine H, Fujita C, Ohbayashi C, Take S, Tanaka Y, Itoh T, Arima N. PMID: 42816412 [PubMed - indexed for MEDLINE]
	POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder and skin changes) associated with Castleman disease and latent tuberculosis: a diagnostic challenge. BMJ Case Rep Kaudlay Sathyanarayana PK, Mathew K, Murtaza G, St Pierre-Robson K, Vega Gonzalez M. PMID: 42816105 [PubMed - indexed for MEDLINE]
	Treatment Patterns and Clinical Outcomes Among Chinese Patients With Newly Diagnosed Multiple Myeloma: A Multicenter Retrospective Study (CHAMP-MM). Cancer Med Cui J, Qu X, Li C, Li F, Zhong L, Fu X, Liu G, Qiu L, An G. PMID: 42813301 [PubMed - indexed for MEDLINE]
	Myeloid-derived suppressor cells in multiple myeloma: mechanistic insights and therapeutic implications. Front Immunol Wen J, Zhou Q, Yue J, Zhang Y, Zheng Y, Xu F. PMID: 42812873 [PubMed - indexed for MEDLINE]
	Haematological toxicity associated with antineoplastic drugs: a pharmacovigilance analysis based on the FDA adverse event reporting system database. Front Immunol Xu X, Ma L. PMID: 42812320 [PubMed - indexed for MEDLINE]
	Next Generation Sequencing in the Diagnosis of Multiple Myeloma. Front Biosci (Schol Ed) El Fazazi I, Ihlal H, Ouskri A, Nmer S, Washenko A, El Mouhi H, Abbassi M, Ahakoud M, Bouguenouch L, Berrady R, Ouldim K, El-Azami-El-Idrissi M. PMID: 42812037 [PubMed - indexed for MEDLINE]
	Uveitis as a class effect of Bruton tyrosine kinase inhibitors: ibrutinib and zanubrutinib ocular toxicity. BMJ Case Rep Beresford O, Ooi ZY, Al-Bermani A. PMID: 42810753 [PubMed - indexed for MEDLINE]
	Toward a Cure in Multiple Myeloma: Redefining Induction Therapy and the Role of Autologous Stem Cell Transplant. Cancer J Joshi A, Puliafito BR, Cirstea DD, Branagan AR, Gustine JN, Shome R, Panaroni C, Yee AJ, Raje NS. PMID: 42809701 [PubMed - indexed for MEDLINE]
	Tailoring Therapy for Frail and Elderly Myeloma Patients. Cancer J George T, Szalat RE. PMID: 42809700 [PubMed - indexed for MEDLINE]
	Managing Novel CAR T-Cell Toxicities in Multiple Myeloma. Cancer J Ang KK, Lipof J, Kumar A, Mikkilineni L, Chung A, Arora S, Sayre P, Wolf J, Chari A, Martin T, Pan D. PMID: 42809699 [PubMed - indexed for MEDLINE]
	T-Cell Redirecting Antibodies for the Treatment of Multiple Myeloma: Off-the-Shelf T-Cell Immunity. Cancer J van de Donk NWCJ, Smits F, O'Neill C, Hoekman J, Kruyswijk S, Baglio SR, Zweegman S, Korst CLBM. PMID: 42809698 [PubMed - indexed for MEDLINE]
	CAR-T Cell Therapy: Engineering Remission in Refractory Myeloma. Cancer J Sperling AS. PMID: 42809697 [PubMed - indexed for MEDLINE]
	Minimal Residual Disease (MRD) in Multiple Myeloma: From Prognostic Marker to Therapeutic Compass. Cancer J Tamariz-Amador LE, Rodriguez-Otero P, Manubens A, Lasa M, Gonzalez C, Paiva B, San-Miguel J. PMID: 42809696 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 93967

Seite 1 von 4699

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung